Vascular and endothelial regeneration

Current Stem Cell Research and Therapy

Volumn 5, Issue 2, 2010, Pages 141-144

  Casteilla, Louis ^a,b   Planat Bénard, Valérie ^a,b   Cousin, Béatrice ^a,b   Laharrague, Patrick ^a,b,c   Bourin, Philippe ^d  

^a Institut National de la Sant é et de la Recherche Medicale   (France)

^b CNRS   (France)

^c TOULOUSE UNIVERSITY HOSPITAL   (France)

^d EFS   (France)

Author keywords

Adipose tissue; Cell therapy; Endothelial cells; Mesenchymal cells; Plasticity; Stems cells

Indexed keywords

CD31 ANTIGEN; CD34 ANTIBODY; CHEMOKINE RECEPTOR CXCR4; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ADIPOCYTE; ADIPOSE DERIVED STEM CELL; ADIPOSE TISSUE; ALLOGENEIC STEM CELL TRANSPLANTATION; ANGIOGENESIS; ARTICLE; BONE MARROW; CELL REGENERATION; CELL THERAPY; CRYOPRESERVATION; ENDOTHELIUM CELL; HYPOXIA; IMMUNOMODULATION; MESENCHYMAL STEM CELL; MULTIPOTENT STEM CELL; PHENOTYPE; PRIORITY JOURNAL; REGENERATIVE MEDICINE; SMOOTH MUSCLE FIBER; ANIMAL; BLOOD VESSEL; CELL TRANSDIFFERENTIATION; HUMAN; INDUCED PLURIPOTENT STEM CELL; ISCHEMIA; METABOLISM; PATHOLOGY; SMOOTH MUSCLE CELL; STEM CELL TRANSPLANTATION;

ADIPOSE TISSUE; ANIMALS; BLOOD VESSELS; CELL TRANSDIFFERENTIATION; HUMANS; INDUCED PLURIPOTENT STEM CELLS; ISCHEMIA; MYOCYTES, SMOOTH MUSCLE; NEOVASCULARIZATION, PHYSIOLOGIC; STEM CELL TRANSPLANTATION;

EID: 77954067693     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488810791268546     Document Type: Article

References (61)

1. Ailhaud G. Adipose tissue as an endocrine organ. Int J Obes RelatMetab Disord 2000; 24(Suppl 2): S1-3.
2. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J ClinEndocrinol Metab 2004; 89: 2548-56.
3. Himms-Hagen J. Brown adipose tissue thermogenesis: interdisciplinary studies. FASEB J 1990; 4: 2890-8.
4. Bourlier V, Bouloumie A. Role of macrophage tissue infiltration inobesity and insulin resistance. Diabetes Metab 2009; 35(4): 251-60.Epub 2009.
5. Caspar-Bauguil S, Cousin B, Galinier A, et al. Adipose tissues asan ancestral immune organ: site-specific change in obesity. FEBSLett 2005; 579: 3487-92.
6. McIntosh K, Zvonic S, Garrett S, et al. The immunogenicity ofhuman adipose-derived cells: temporal changes in vitro. Stem Cells 2006; 24: 1246-53.
7. Planat-Benard V, Silvestre JS, Cousin B, et al. Plasticity of humanadipose lineage cells toward endothelial cells: physiological andtherapeutic perspectives. Circulation 2004; 109: 656-63.
8. Ailhaud G, Grimaldi P, Negrel R. Cellular and molecular aspects ofadipose tissue development. Annu Rev Nutr 1992; 12: 207-33.
9. Zuk PA, Zhu M, Mizuno H, et al. Multilineage cells from humanadipose tissue: implications for cell-based therapies. Tissue Eng 2001; 7: 211-28.
10. Guilak F, Lott KE, Awad HA, et al. Clonal analysis of the differentiation potential of human adipose-derived adult stem cells. J CellPhysiol 2006; 206: 229-37.
11. Gimble JM, Katz AJ, Bunnell BA. Adipose-derived stem cells forregenerative medicine. Circ Res 2007; 100: 1249-60.
12. Baulande S, Feve B. Identification of new genes associated withadipogenesis. Med Sci (Paris) 2003; 19: 151-4.
13. Negrel R, Grimaldi P, Forest C, Ailhaud G. Establishment andcharacterization of fibroblast-like cell lines derived from adipo-cytes with the capacity to redifferentiate into adipocyte-like cells.Methods Enzymol 1985; 109: 377-85.
14. Gesta S, Tseng YH, Kahn CR. Developmental origin of fat: tracking obesity to its source. Cell 2007; 131: 242-56.
15. Billon N, Monteiro MC, Dani C. Developmental origin of adipo-cytes: new insights into a pending question. Biol Cell 2008; 100:563-75.
16. Casteilla L, Planat-Benard V, Cousin B, et al. Plasticity of adiposetissue: a promising therapeutic avenue in the treatment of cardio-vascular and blood diseases? Arch Mal Coeur Vaiss 2005; 98: 922-6.
17. Wassermann P. The development of adipose tissue. Handbook ofPhysiology. In: Renold AE, Cahill G, Eds. Adipose tissue Washington American Physiological Society, 1989; 87: 100.
18. Rupnick MA, Panigrahy D, Zhang CY, et al. Adipose tissue masscan be regulated through the vasculature. Proc Natl Acad Sci USA2002; 99: 10730-5.
19. Kolonin MG, Saha PK, Chan L, Pasqualini R, Arap W. Reversal ofobesity by targeted ablation of adipose tissue. Nat Med 2004; 10:625-32.
20. Rehman J, Traktuev D, Li J, et al. Secretion of angiogenic andantiapoptotic factors by human adipose stromal cells. Circulation 2004; 109: 1292-8.
21. Traktuev DO, Merfeld-Clauss S, Li J, et al. A population of multipotent CD34-positive adipose stromal cells share pericyte andmesenchymal surface markers, reside in a periendothelial location,and stabilize endothelial networks. Circ Res 2008; 102: 77-85.
22. Miranville A, Heeschen C, Sengenes C, et al. Improvement ofpostnatal neovascularization by human adipose tissue-derived stemcells. Circulation 2004; 110: 349-55.
23. Martinez-Estrada OM, Munoz-Santos Y, Julve J, Reina M, Vilaro S. Human adipose tissue as a source of Flk-1+ cells: new method ofdifferentiation and expansion. Cardiovasc Res 2005; 65: 328-33.
24. Sengenes C, Miranville A, Maumus M, et al. Chemotaxis anddifferentiation of human adipose tissue CD34+/CD31- progenitorcells: role of stromal derived factor-1 released by adipose tissuecapillary endothelial cells. Stem Cells 2007; 25: 2269-76.
25. Cao Y, Sun Z, Liao L, et al. Human adipose tissue-derived stemcells differentiate into endothelial cells in vitro and improve post-natal neovascularization in vivo. Biochem Biophys Res Commun 2005; 332: 370-9.
26. Carriere A, Carmona MC, Fernandez Y, et al. Mitochondrial reactive oxygen species control the transcription factor CHOP-10/GADD153 and adipocyte differentiation: a mechanism for hypoxia-dependent effect. J Biol Chem 2004; 279: 40462-9.
27. Yun Z, Maecker HL, Johnson RS, Giaccia AJ. Inhibition of PPARgamma 2 gene expression by the HIF-1-regulated geneDEC1/Stra13: a mechanism for regulation of adipogenesis by hypoxia. Dev Cell 2002; 2: 331-41.
28. Trayhurn P, Wang B, Wood IS. Hypoxia in adipose tissue: a basisfor the dysregulation of tissue function in obesity? Br J Nutr 2008;100: 227-35.
29. Carriere A, Ebrahimian TG, Dehez S, et al. Preconditioning bymitochondrial reactive oxygen species improves the proangiogenicpotential of adipose-derived cells-based therapy. ArteriosclerThromb Vasc Biol 2009; 29: 1093-9.
30. Cai L, Johnstone BH, Cook TG, et al. Suppression of hepatocytegrowth factor production impairs the ability of adipose-derivedstem cells to promote ischemic tissue revascularization. Stem Cells 2007; 25: 3234-43.
31. Bell LN, Cai L, Johnstone BH, et al. A central role for hepatocytegrowth factor in adipose tissue angiogenesis. Am J Physiol Endocrinol Metab 2008; 294: E336-44.
32. Sadat S, Gehmert S, Song YH, et al. The cardioprotective effect ofmesenchymal stem cells is mediated by IGF-I and VEGF. BiochemBiophys Res Commun 2007; 363: 674-9.
33. Kilroy GE, Foster SJ, Wu X, et al. Cytokine profile of human adipose-derived stem cells: expression of angiogenic, hematopoietic,and pro-inflammatory factors. J Cell Physiol 2007; 212: 702-9.
34. Valina C, Pinkernell K, Song YH, et al. Intracoronary administra-tion of autologous adipose tissue-derived stem cells improves leftventricular function, perfusion, and remodelling after acute myo-cardial infarction. Eur Heart J 2007; 28: 2667-77.
35. Mazo M, Planat-Benard V, Abizanda G, et al. Transplantation ofadipose derived stromal cells is associated with functional im-provement in a rat model of chronic myocardial infarction. Eur JHeart Fail 2008; 10: 454-62.
36. Ebrahimian TG, Pouzoulet F, Squiban C, et al. Cell therapy basedon adipose tissue-derived stromal cells promotes physiological andpathological wound healing. Arterioscler Thromb Vasc Biol 2009;29: 503-10.
37. Kim WS, Park BS, Sung JH, et al. Wound healing effect of adi-pose-derived stem cells: a critical role of secretory factors on hu-man dermal fibroblasts. J Dermatol Sci 2007; 48: 15-24.
38. Kim WS, Park BS, Park SH, Kim HK, Sung JH. Antiwrinkle effectof adipose-derived stem cell: activation of dermal fibroblast by se-cretory factors. J Dermatol Sci 2009; 53: 96-102.
39. Kubis N, Tomita Y, Tran-Dinh A, et al. Vascular fate of adiposetissue-derived adult stromal cells in the ischemic murine brain: Acombined imaging-histological study. Neuroimage 2007; 34: 1-11.
40. Crisan M, Deasy B, Gavina M, et al. Purification and long-termculture of multipotent progenitor cells affiliated with the walls ofhuman blood vessels: myoendothelial cells and pericytes. MethodsCell Biol 2008; 86: 295-309.
41. Jack GS, Almeida FG, Zhang R, et al. Processed lipoaspirate cellsfor tissue engineering of the lower urinary tract: implications forthe treatment of stress urinary incontinence and bladder reconstruction. J Urol 2005; 174: 2041-5.
42. Jeon ES, Moon HJ, Lee MJ, et al. Sphingosylphosphorylcholineinduces differentiation of human mesenchymal stem cells intosmooth-muscle-like cells through a TGF-beta-dependent mecha-nism. J Cell Sci 2006; 119: 4994-5005.
43. Lee WC, Rubin JP, Marra KG. Regulation of alpha-smooth muscleactin protein expression in adipose-derived stem cells. Cells Tissues Organs 2006; 183: 80-6.
44. Lee WC, Maul TM, Vorp DA, Rubin JP, Marra KG. Effects ofuniaxial cyclic strain on adipose-derived stem cell morphology,proliferation, and differentiation. Biomech Model Mechanobiol 2007; 6: 265-73.
45. Rodriguez LV, Alfonso Z, Zhang R, et al. Clonogenic multipotentstem cells in human adipose tissue differentiate into functionalsmooth muscle cells. Proc Natl Acad Sci USA 2006; 103: 12167-72.
46. Abderrahim-Ferkoune A, Bezy O, Astri-Roques S, et al. Transdifferentiation of preadipose cells into smooth muscle-like cells: roleof aortic carboxypeptidase-like protein. Exp Cell Res 2004; 293:219-28.
47. Gagnon A, Abaiian KJ, Crapper T, Layne MD, Sorisky A. Down-regulation of aortic carboxypeptidase-like protein during the earlyphase of 3T3-L1 adipogenesis. Endocrinology 2002; 143: 2478-85.
48. Gagnon A, Landry A, Proulx J, Layne MD, Sorisky A. Aorticcarboxypeptidase-like protein is regulated by transforming growthfactor beta in 3T3-L1 preadipocytes. Exp Cell Res 2005; 308: 265-72.
49. Kern S, Eichler H, Stoeve J, Kluter H, Bieback K. Comparativeanalysis of mesenchymal stem cells from bone marrow, umbilicalcord blood, or adipose tissue. Stem Cells 2006; 24: 1294-301.
50. Wagner W, Roderburg C, Wein F, et al. Molecular and secretoryprofiles of human mesenchymal stromal cells and their abilities tomaintain primitive hematopoietic progenitors. Stem Cells 2007; 25:2638-47.
51. Tateishi-Yuyama E, Matsubara H, Murohara T, et al. Therapeuticangiogenesis for patients with limb ischaemia by autologous trans-plantation of bone-marrow cells: a pilot study and a randomisedcontrolled trial. Lancet 2002; 360: 427-35.
52. Kim Y, Kim H, Cho H, et al. Direct comparison of human mesen-chymal stem cells derived from adipose tissues and bone marrow inmediating neovascularization in response to vascular ischemia. CellPhysiol Biochem 2007; 20: 867-76.
53. Tamarat R, Silvestre JS, Le Ricousse-Roussanne S, et al. Impair-ment in ischemia-induced neovascularization in diabetes: bonemarrow mononuclear cell dysfunction and therapeutic potential ofplacenta growth factor treatment. Am J Pathol 2004; 164: 457-66.
54. Miyahara Y, Nagaya N, Kataoka M, et al. Monolayered mesen-chymal stem cells repair scarred myocardium after myocardial infarction. Nat Med 2006; 12: 459-65.
55. Meyerrose TE, De Ugarte DA, Hofling AA, et al. In vivo distribu-tion of human adipose-derived mesenchymal stem cells in novelxenotransplantation models. Stem Cells 2007; 25: 220-7.
56. Madonna R, Rinaldi L, Rossi C, Geng YJ, De Caterina R. Prosta-cyclin improves transcoronary myocardial delivery of adipose tissue-derived stromal cells. Eur Heart J 2006; 27: 2054-61.
57. Puissant B, Barreau C, Bourin P, et al. Immunomodulatory effectof human adipose tissue-derived adult stem cells: comparison withbone marrow mesenchymal stem cells. Br J Haematol 2005; 129:118-29.
58. Fang B, Song YP, Liao LM, Han Q, Zhao RC. Treatment of severetherapy-resistant acute graft-versus-host disease with human adi-pose tissue-derived mesenchymal stem cells. Bone Marrow Transplant 2006; 38: 389-90.
59. Yanez R, Lamana ML, Garcia-Castro J, et al. Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressiveproperties applicable for the control of the graft-versus-host disease. Stem Cells 2006; 24: 2582-91.
60. Fang B, Song Y, Liao L, Zhang Y, Zhao RC. Favorable response tohuman adipose tissue-derived mesenchymal stem cells in steroid-refractory acute graft-versus-host disease. Transplant Proc 2007;39: 3358-62.
61. Goh BC, Thirumala S, Kilroy G, Devireddy RV, Gimble JM.Cryopreservation characteristics of adipose-derived stem cells:maintenance of differentiation potential and viability. J Tissue EngRegen Med 2007; 1: 322-4.